Event FinderExpert Led Panel: The future of cutting edge genomic technologies for liquid biopsy cancer research
- Starts
- Ends
- Format
- Online
- Location
- VIRTUAL
About This Event
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsies are less risky, painful, and costly, and are increasingly being used to analyze biomarkers in liquid samples, such as blood. Recent advances in genomic technologies, such as digital PCR (dPCR) and next-generation sequencing (NGS), have enabled researchers to more comprehensively detect and study cancer-related mutations, even when they are very rare.